An Expanded Access Program for AM0010 (Pegilodecakin)

Clinical trial NCT03554434 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT03554434
Sponsor: Eli Lilly and Company
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

Melanoma Prostate Cancer Ovarian Cancer Renal Cell Carcinoma Colorectal Carcinoma Pancreatic Carcinoma Non-small Cell Lung Carcinoma Solid Tumors Breast Cancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.